Skip to main content

Table 1 Baseline characteristics (n = 54)

From: The improvement of QRS-T angle as a manifestation of reverse electrical remodeling following renal transplantation in end-stage kidney disease patients on haemodialysis

Characteristic

Value

age [years]

44.6 ± 8.9

gender (men/women) [n (%)]

26 (48.1)/28 (51.9)

time on dialysis until RT [months]

36.65 (±19.34)

haemoglobin [g/dL]

12.43 (±2.89)

sodium [mmol/L]

138.4 (±2.01)

potassium [mmol/L]

4.74 (±1.20)

magnesium [mmol/L]

0.98 (±0.25)

calcium [mmol/L]

2.49 (±0.26)

phosphorus [mmol/L]

1.63 (±0.47)

parathormone [pg/mL]

695.3 (±666.8)

creatinine [μmol/L]

567.2 (±229.3)

urea [mmol/L]

9.54 (±5.34)

total protein [g/L]

74.8 (±13.8)

albumin [g/L]

4.5 (±1.11)

hs-CRP [mg/L]

3.42 (±2.02)

total cholesterol [mg/dL]

223.0 (±62.2)

LDL-cholesterol [mg/dL]

138.0 (±42.18)

HDL-cholesterol [mg/dL]

68.0 (±22.05)

triglycerides [mg/dL]

211.2 (±65.69)

glucose [mg/dL]

92.56 (±42.18)

troponin T [μg/L]

0.019 (±0.035)

treatment prior to RT

 ACE-inhibitors/sartans [n (%)]

36 (66.7)

 calcium blockers [n (%)]

42 (77.8)

 beta-blockers [n (%)]

41 (75.9)

 alfa-blockers [n (%)]

4 (7.4)

 clonidine [n (%)]

2 (3.7)

 statins [n (%)]

26 (48.1)

immunosuppression

 methylprednisolone [n (%)]

54 (100)

 mycophenolate mofetil [n (%)]

52 (96.3)

 cyclosporine [n (%)]

18 (33.3)

 tacrolimus [n (%)]

36 (66.6)

  1. hs-CRP – high-sensitivity C-reactive protein; ACE- inhibitors –angiotensin converting enzyme inhibitors; sartans - angiotensin 2 receptor blockers